Literature DB >> 8201682

Nephron sparing surgery in incidental versus suspected renal cell carcinoma.

M R Licht1, A C Novick, M Goormastic.   

Abstract

From 1956 to 1992 nephron sparing surgery was performed in 216 patients with sporadic renal cell carcinoma. Renal cell carcinoma was suspected in 121 patients and was an incidental finding in 95. Compared to suspected renal cell carcinoma, incidental tumors were smaller (p = 0.0004), more often unilateral (p = 0.001) and of lower pathological stage (p = 0.001). Incidental tumors were also associated with improved 5-year cancer-specific survival (p = 0.003) and a lower rate of postoperative tumor recurrence (p = 0.001). The overall 5-year cancer-specific survival rate was improved in patients with stage I versus higher stage renal cell carcinoma (p = 0.0002), unilateral versus bilateral disease (p = 0.0001), a single versus multiple tumors in the operated kidney (p = 0.01) and tumors smaller than 4 cm. versus larger tumors (p = 0.03). There were no postoperative tumor recurrences and the 5-year cancer-specific survival rate was 100% in patients with unilateral, stage I tumors smaller than 4 cm. These data define specific eligibility criteria for nephron sparing surgery in patients with localized unilateral renal cell carcinoma and a normal contralateral kidney.

Entities:  

Mesh:

Year:  1994        PMID: 8201682     DOI: 10.1016/s0022-5347(17)32810-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

Review 1.  Should there be a size limit for elective nephron-sparing surgery?

Authors:  Kent G Krejci; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

Review 2.  The role of minimally invasive surgery in multifocal renal cell carcinoma.

Authors:  Serge Ginzburg; Robert G Uzzo; Alexander Kutikov
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

3.  Estimated functional renal parenchymal volume predicts the split renal function following renal surgery.

Authors:  Hisakazu Mibu; Nobumichi Tanaka; Yukinari Hosokawa; Hiromi Kumamoto; Nagaaki Margami; Yoshihiko Hirao; Kiyohide Fujimoto
Journal:  World J Urol       Date:  2015-01-03       Impact factor: 4.226

4.  Impact of tumor size on the long-term survival of patients with early stage renal cell cancer.

Authors:  M Kuczyk; G Wegener; A S Merseburger; A Anastasiadis; S Machtens; A Zumbrägel; J T Hartmann; C Bokemeyer; Udo Jonas; A Stenzl
Journal:  World J Urol       Date:  2005-02-24       Impact factor: 4.226

5.  Radical versus partial nephrectomy, chronic kidney disease progression and mortality in US veterans.

Authors:  Elani Streja; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Jaime Landman; Onyebuchi A Arah; Csaba P Kovesdy
Journal:  Nephrol Dial Transplant       Date:  2018-01-01       Impact factor: 5.992

Review 6.  Landmarks in the diagnosis and treatment of renal cell carcinoma.

Authors:  Jaimin R Bhatt; Antonio Finelli
Journal:  Nat Rev Urol       Date:  2014-08-12       Impact factor: 14.432

7.  Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.

Authors:  Jason D Iannuccilli; Damian E Dupuy; Michael D Beland; Jason T Machan; Dragan J Golijanin; William W Mayo-Smith
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

Review 8.  Current controversies in nephron-sparing surgery for renal-cell carcinoma.

Authors:  F Steinbach; M Stöckle; R Hohenfellner
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

9.  Psycho-social well-being and general health status after surgical treatment for localized renal cell carcinoma.

Authors:  Vincenzo Ficarra; Giovanni Novella; Alessandra Sarti; Giacomo Novara; Antonio Galfano; Stefano Cavalleri; Walter Artibani
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

10.  Role of open nephron sparing surgery in the era of minimal invasive surgery.

Authors:  Gaurav Gupta; Sameer Grover; Santosh Kumar; Nitin S Kekre
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.